289 related articles for article (PubMed ID: 29078211)
1. [Personalized therapy of lung cancer - current standard and future challenges].
Riedel R; Wolf J
Dtsch Med Wochenschr; 2017 Nov; 142(22):1660-1668. PubMed ID: 29078211
[TBL] [Abstract][Full Text] [Related]
2. [Targeted therapy and precision medicine : More than just words in the treatment of lung cancer].
Heigener DF; Horn M; Reck M
Internist (Berl); 2016 Dec; 57(12):1243-1249. PubMed ID: 27587193
[TBL] [Abstract][Full Text] [Related]
3. Successes and limitations of targeted cancer therapy in lung cancer.
Suda K; Mitsudomi T
Prog Tumor Res; 2014; 41():62-77. PubMed ID: 24727987
[TBL] [Abstract][Full Text] [Related]
4. Evolving Cancer Classification in the Era of Personalized Medicine: A Primer for Radiologists.
O'Neill AC; Jagannathan JP; Ramaiya NH
Korean J Radiol; 2017; 18(1):6-17. PubMed ID: 28096714
[TBL] [Abstract][Full Text] [Related]
5. Targeted Therapy for Patients With Metastatic Non-Small Cell Lung Cancer.
Reckamp KL
J Natl Compr Canc Netw; 2018 May; 16(5S):601-604. PubMed ID: 29784736
[TBL] [Abstract][Full Text] [Related]
6. Targeted Therapies for Lung Cancer.
Stinchcombe TE
Cancer Treat Res; 2016; 170():165-82. PubMed ID: 27535394
[TBL] [Abstract][Full Text] [Related]
7. [News about targeted therapies in non-small-cell lung cancer in 2015 (except immuno-therapy)].
Hamard C; Ruppert AM; Lavole A; Rozensztajn N; Antoine M; Cadranel J; Wislez M
Ann Pathol; 2016 Jan; 36(1):63-72. PubMed ID: 26775573
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.
Kang HN; Choi JW; Shim HS; Kim J; Kim DJ; Lee CY; Hong MH; Park SY; Park AY; Shin EJ; Lee SY; Pyo KH; Yun MR; Choi HM; Lee SS; Kim SY; Lee H; Paik S; Cho BC; Lee JG; Kim HR
Lung Cancer; 2018 Oct; 124():168-178. PubMed ID: 30268457
[TBL] [Abstract][Full Text] [Related]
9. Current status of targeted therapy in non-small cell lung cancer.
Parums DV
Drugs Today (Barc); 2014 Jul; 50(7):503-25. PubMed ID: 25101332
[TBL] [Abstract][Full Text] [Related]
10. Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.
Vari S; Pilotto S; Maugeri-Saccà M; Ciuffreda L; Cesta Incani U; Falcone I; Del Curatolo A; Ceribelli A; Gelibter A; De Maria R; Tortora G; Cognetti F; Bria E; Milella M
Expert Opin Drug Discov; 2013 Nov; 8(11):1381-97. PubMed ID: 24088065
[TBL] [Abstract][Full Text] [Related]
11. Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer.
Halliday PR; Blakely CM; Bivona TG
Curr Oncol Rep; 2019 Feb; 21(3):21. PubMed ID: 30806814
[TBL] [Abstract][Full Text] [Related]
12. The Role of Targeted Agents and Immunotherapy in Older Patients with Non-small Cell Lung Cancer.
Gomes F; Tay R; Chiramel J; Califano R
Drugs Aging; 2018 Sep; 35(9):819-834. PubMed ID: 30105645
[TBL] [Abstract][Full Text] [Related]
13. Targeted Therapy for Non-Small Cell Lung Cancer.
Noor ZS; Cummings AL; Johnson MM; Spiegel ML; Goldman JW
Semin Respir Crit Care Med; 2020 Jun; 41(3):409-434. PubMed ID: 32450595
[TBL] [Abstract][Full Text] [Related]
14. [Not Available].
Evers G; Mohr M; Kerkhoff A; Lenz G; Wiewrodt R; Schmidt LH
Dtsch Med Wochenschr; 2017 Oct; 142(20):1531-1534. PubMed ID: 29017211
[TBL] [Abstract][Full Text] [Related]
15. Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer.
Nokin MJ; Ambrogio C; Nadal E; Santamaria D
Trends Cancer; 2021 May; 7(5):410-429. PubMed ID: 33309239
[TBL] [Abstract][Full Text] [Related]
16. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials.
Alden RS; Mandrekar SJ; Oxnard GR
Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304
[TBL] [Abstract][Full Text] [Related]
17. Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition.
Facchinetti F; Rossi G; Bria E; Soria JC; Besse B; Minari R; Friboulet L; Tiseo M
Cancer Treat Rev; 2017 Apr; 55():83-95. PubMed ID: 28342334
[TBL] [Abstract][Full Text] [Related]
18. A Predictive Model for Personalized Therapeutic Interventions in Non-small Cell Lung Cancer.
Kureshi N; Abidi SS; Blouin C
IEEE J Biomed Health Inform; 2016 Jan; 20(1):424-31. PubMed ID: 25494516
[TBL] [Abstract][Full Text] [Related]
19. Emerging targeted therapies in non-small cell lung cancer.
Khanal N; Ganti AK
Expert Rev Anticancer Ther; 2016; 16(2):177-87. PubMed ID: 26618563
[TBL] [Abstract][Full Text] [Related]
20. Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.
Califano R; Abidin A; Tariq NU; Economopoulou P; Metro G; Mountzios G
Cancer Treat Rev; 2015 May; 41(5):401-11. PubMed ID: 25842168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
